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Abstract 
 
Background: Maternal mortality is still a major problem in developing countries. In 2015, 
World Health Organization estimated the Maternal Mortality Rate (MMR) in developing 
countries was as high as 239 per 100,000 live births, while it was as low as 12 in developed 
countries. According to the data, this indicates the failure of many developing countries in 
achieving Millennium Development Goals (MDG), nevertheless the awareness of which is still 
low. Moreover, maternal death also immensely affects the growth and development of a child, 
which can lead to a reduced child’s life quality. In fact, 25% of maternal deaths are caused by 
Preeclampsia, hence it is still a global burden, and has to be controlled to achieve Sustainable 
Development Goals in 2030. In addition, a population-specific systematic review of maternal 
factors associated with preeclampsia among Asian has not been done before. Aim: This study 
reports a systematic review to identify factors associated with preeclampsia among Asian in 
order to reduce its incidence through increasing awareness and screening quality of 
preeclampsia. Material and method: A systematic review was conducted on cohort studies 
concerning the factors associated with preeclampsia among Asian. Cohort studies were chosen 
as it is a time-based study, therefore compatible to identify the risk of preeclampsia, based on 
pathogenesis during pregnancy time. 6133 records, related with preeclampsia among Asian, 
were found from Pubmed. We exclude publications that did not meet inclusion criteria (n = 
6037), then which meet exclusion criteria (n = 81). Finally, three reviewers extracted data from 
total included study (n = 15)  and we assested the studies with STROBE statement to show the 
quality of each studies. Results: There were 375.622 participants among 15 studies. The 
studies show that factors associated with preeclampsia are: maternal BMI, maternal weight 
gain during pregnancy, maternal age, history of gestational hypertension and preecalmpsia, 
diabetes mellitus, gravida and parrity, etc. Risk factors with highest odd ratio are pre-
gestational obese (OR: 7.85); chronic hypertension (OR: 7.174); and previous history of 
gestational hypertension or preeclampsia (OR: 8.85). On the other hand, weight gain below 
IOM in overweight pre-gestational weight (OR: 0.76), isolated anti TPO antibody (OR: 0.7), 
normal BMI with BPD >90 (OR: 0.86), and maternal weight gain <10kg (OR: 0.5) are shown 
to be protective factors of preeclampsia. Furthermore, maternal BMI, history of gestational 
hypertension and preeclampsia are risk factors of preeclampsia which most discussed  and 
could be a complex issues among Asian countries. Conclusion: From this systematic review, 
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maternal BMI (overweight and obese), inappropriate maternal weight gain, and history of pre-
gestational hypertension and preeclampsia, were proven to be the highest risk of preeclampsia 
among Asian women. Other risks of which are maternal age, mother’s education, mother 
activity, DM and hypothyroidism. With this knowledge, we aim this review to improve the 
quality of preeclampsia screening and awareness of physicians and mothers regarding the 
problem or even develop a practical evidence based list of risk factors related to preeclampsia 
among Asian, which can be assesed by health care worker.  
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Background 
 
Preeclampsia is a potentially dangerous 
pregnancy complication caused by vascular 
endothelial malfunction disorder. As the 
highest contributor in maternal mortality, 
preeclampsia is still a global burden, 
especially in developing countries. In fact, 
every day, at least 76,000 from 290,000 
deaths, translating to 25% of all deaths of 
mothers all over the world, are accounted to 
preeclampsia. In 2015, World Health 
Organization estimated the Maternal 
Mortality Rate in developing countries was 
as high as 239 per 100,000 live births, while 
it was as low as 12 in developed countries. 
The significance of the problem is also 
shown in data of maternal death risk, which 
is 1 in 180 in developing countries, 
compared to 1 in 4900 in developed 
countries.1 This huge gap was then worsen 
by the data that many developing countries 
failed to achieve Millennium Development 
Goals (MDGs) in reducing maternal 
mortality rate. Our beloved homeland, 
Indonesia, for example, still has the MMR 
twice the initial expected number, which is 
of 305 deaths compared to 102 deaths per 
100,000 live births. This indicates the lack 
of knowledge and awareness towards the 
causes of maternal death.2 
 
Moreover, maternal death also deeply 
affects the growth and development of a 
child. Without the presence of a well-built 
mother and child attachment, the 
establishment of cognitive, physical, social, 
and emotional capacity of a child could be 
impaired. Not only affecting the family, 
preeclampsia also causing disadvantages to 
the country. Treatment of preeclampsia in 
the United States has cost more than 2.18 
billion US dollar per year. With the MMR 
significantly higher in developing 
countries, it can be conceived how 
developing countries are economically 
burdened.3  
 
In addition, a population-specific 
systematic review of maternal factors 
associated with preeclampsia among Asian 
has not been done before. Our systematic 
review stands as the new strategy to reduce 
MMR in Sustainable Development Goals, 
and agenda that serves as a continuation of 
MDGs, to 70 deaths per 100,000 live births.  
 
Objective  
 
To identify factors associated with 
preeclampsia among Asian in order to 
reduce its incidence through increasing 
awareness and screening quality of 
preeclampsia 
 
Method 
 
We conducted a systematic review of large 
cohort studies concerning the factors 
associated with preeclampsia among Asian. 
Cohort studies were chosen, as it is a time-
period approach, due to it’s compatibility to 
identify the risk of preeclampsia based on 
its pathogenesis during a definite 
pregnancy time.  
 
 
Figure 1. Conceptual Framework 
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From Pubmed Database, 6133 records were 
identified from all time until October 2017. 
For the search strategy we used 
combinations of several terms: 
“preeclampsia OR pre-eclampsia OR PE”, 
“risk factor OR factor OR risk”, “Asian OR 
Asia”, “cohort OR prospective study OR 
retrospective study”. We only included 
prospective and retrospective cohort studies 
identifying the risk factor of preeclampsia 
with Asian as the spesific population 
sample. We excluded the study which is not 
written in English and the study which 
published not in Asia region due to the 
reason that Asian who lived outside the 
continent might have changed their life 
style distinctively. Studies identifying 
biomolecular or genetic factor were also 
excluded, because we would like to identify 
factor which is common, preventable and 
can be altered in order to reduce the number 
of preeclampsia. Then, 6037 publications 
that did not meet inclusion criteria and 
another 81 publications that met the 
exclusion criteria were excluded, resulting 
in the final 15 total included studies [Figure 
1]. 
 
Furthermore, data from the total included 
studies were extracted and assessed with 
STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) 
statement spesificaly for cohort study to 
show the quality of each publications. Data 
extraction and STROBE  statement 
assessment was done by three reviewers, 
which had been equalized and trained in 
using STROBE Statment as assessing tool. 
In addition, each study was assessed and 
evaluated three times by different reviewer 
in order to reduce human error and bias of 
data extraction or STROBE statement 
assessment.  
 
We abstracted information from the 
publications on: study design, location of 
study, sample size, gestational age, mean 
age of sample, method of analysis, outcome 
(associated factor and its odd ratio). As 
mentioned before, quality of each cohort 
study we assessed them with STROBE 
statement, so they could be qualitatively 
compared with equal assessment. 
 
Result 
 
Characteristic of Included Studies 
The total participants included in this 
systematic review were 375.622 from 15 
studies. This included studies are 
summarised in [Table 1].  
 
Risk factors of preeclampsia that are most 
discussed in the studies and problematic in 
Asia are maternal BMI and history of 
gestational hypertension and preeclampsia. 
The Odd Ratios of the risk factors are 7.85 
and 8.85, respectively, causing both factors 
to have highest OR compared to another 
factors. Other risk factor that has high OR 
is chronic hypertension (OR: 7.174). On the 
other hand, the protective factors of 
preeclampsia are weight gain below IOM in 
overweight pre-gestational weight (OR: 
0.76), isolated anti-TPO antibody, normal 
BMI, BPD >90 (ORs: 0.86), maternal 
weight gain <10 kg and maternal weight 
gain ≥ 16 kg (ORs: 0.6) [Figure 2]. In 
addition, The best study of which, 
according to STROBE Statement, is a 
2015-publication by Li X et al. The study 
scores 20.4 out of maximum 22 points. 
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Figure 2. Bar Diagram of Variable Distribution of 
Cohort Studies 
 
Discussion 
 
Preeclampsia is described as an pregnancy-
specific syndrome which could affect every 
organ system virtually. It is characterised 
by hypertension which could damage to 
another organ system, most often the 
kidneys, then cause proteinuria which also 
manifest as oedema in both of hands and 
feet. According to summarised result of 
included studies in [Table 1], preeclampsia 
is well-known as a multifactorial disorder. 
There are several factors associated with 
preeclampsia, nevertheless we will discuss 
the top-3 factors related to occurrence of 
preeclampsia among Asian. 
 
Maternal Body Mass Index 
 
Studies have confirmed that inappropriate 
pre-gestational weight is associated with 
increased risks of preeclampsia. According 
to Hung TH, women with overweight and 
obese pre-gestational BMI carried a 3.7 
fold and 7.85 fold increased risk of 
preeclampsia respectively.5 Li X also 
showed overweight pre-gestational BMI to 
escalate the risk of preeclampsia by 1.98 
and obese by 3.41.6 On the other hand 
according to Park JH, Leung TY 
underweight category is less influential and 
tends to be a protective factor7,8 Although, 
underweight pregestational BMI is a 
protective factor of preeclampsia, it 
increases risk of morbidity and mortality in 
infants. The positive relationship is 
supported by the fact that women with 
obese pre-gestational BMI have 
significantly elevated levels of IL-6 and C-
reactive protein in serum, along with 
impaired endothelial function.20 Currently, 
Asia is widely using the BMI standard 
based on WHO’s. However, referring to 
that standard, obese people in Asia are 
prone to having a larger waist 
circumference than Caucasian. This implies 
the need of adjustment of BMI Standard in 
Asia.20 
 
Maternal Age 
 
Several studies have confirmed that 
advanced maternal age is associated with 
adverse pregnancy outcomes. Advanced 
maternal age increases the risk of 
preeclampsia exponentially. According to 
Islam MM, maternal age equal to or more 
than 35 years increased the risk by 3 times.8 
Li X also showed a similar increased risk 
by 3.34 times with maternal age above 35.12  
Moreover, in another study from Funai EF, 
maternal age above 40 increased the risk by 
4.19 fold.6 Maternal age is a multifactorial 
risk of preeclampsia, which is related with: 
glucose intolerance due to insulin 
insensitivity, abnormal lipid profile, 
hypertensive disorder, etc.20 
 
Hypertension and History of Preeclampsia 
 
Hypertension and history of preeclampsia 
have great contribution in increasing risk of 
preeclampsia. According to Yu S, risk of 
preeclampsia increase 7.714-fold in mother 
with chronic hypertension.19 On other study 
by Taguchi T showed that previous history 
of hypertension and preeclampsia had 8.85 
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times of risk of having preeclampsia in 
multipara gestation.17  Preeclampsia is 
initiated by placental ischemia which 
increases total peripheral resistance via 
cytokines reaction. Then, it leads 
hypertension and becomes preeclampsia.20 
Although patophysiology of preeclampsia 
remains unclear, many studies showed that 
incidence of preeclampsia is higher among 
women with previous history of 
hypertension and preeclampsia. Therefore, 
for the mother having these risks, we 
suggest to be more aware before having 
another conception and should check for 
ante natal care when they are pregnant. 
 
Study Limitations 
 
The main limitation of our review are:  the 
uneven distribution of respondents, small 
number of studies, and extreme 
heterogeneity among Asian. The uneven 
distribution of respondents is caused as 
some Asians might have migrated outside 
the continent, which may not be assessed to 
the studies. Moreover, the study of 
preeclampsia among Asian is not as many 
as studies in Caucasians, indicating the 
study of which is still low with the extreme 
heterogeneity among Asian. Therefore, the 
risk factors mentioned in this review may 
just affect considerably in some 
populations which have similar/closly 
related culture, habit or gene.  
Conclusion 
 
From this systematic review, maternal BMI 
(overweight and obese), maternal age, pre-
gestational hypertension and hystory of 
preeclampsia were proven to be the most 
influential and common risks of 
preeclampsia among Asian. Moreover, 
other risks of which are inappropriate 
maternal weight gain, low mother’s 
education and activity, DM and 
hypothyroidism. With this knowledge, we 
aim this review to improve the quality of 
preeclampsia screening and awareness of 
physicians and mothers regarding the 
problem. Furthermore, we hope that this 
review could develop a practical evidence-
based list of risk factors related to 
preeclampsia among Asian which can be 
assessed by primary health care worker. 
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Table 1. Characteristics of Studies and STROBE’s scoring 
Author and 
Year of 
Publication  
Study Design Location 
of Study 
Sample 
Size 
Gestational 
Age 
Mean Age 
of Sample 
Method of Analysis Outcome Strobe 
Boriboonhirun-
sam D, et al. 
2017.5 
Retrospective 
cohort 
Bangkok 300 11.3 w 34.3 Logistic regression, 
Chi-square, Student 
T-test,  
Mean arterial pressure 
≥105 mmHg in 24-28 
weeks of gestational age 
(OR: 1.8) 
15.8 
Funai EF, et al. 
2005.6 
Retrospective 
cohort 
Jerusalem 82 436  N/A 27 Logistic regression  Primigravida (OR:2.8); 
mother's education 0-4 
(OR: 1.87); mothers 
education 5-12 (OR: 1.44) ; 
house wife (OR: 0.98); 
diabetes (OR: 5.25); 
maternal age 35-39 (OR: 
1.68); maternal age >40 
(OR: 4.19); fetal 
haemolytic disease (OR: 
2.31) 
16 
Hung TH, et 
al. 2016.7 
Retrospective 
cohort 
Taipei, 
Taiwan 
10.973 37 w N/A Multivariable 
logistic regression, 
Chi- square,  
Pre-gestational overweight 
(OR:3.74); pre-gestational 
obese (OR: 7.85); weight 
gain below IOM in 
underweight pre-gestational 
weight (OR: 1.72); weight 
gain above IOM in 
underweight preg-estational 
weight (OR: 4.58); weight 
17.3 
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Author and 
Year of 
Publication  
Study Design Location 
of Study 
Sample 
Size 
Gestational 
Age 
Mean Age 
of Sample 
Method of Analysis Outcome Strobe 
gain below IOM in normal 
pre-gestational weight (OR: 
1.13); weight gain above 
IOM in normal pre-
gestational weight 
(OR:3.65); weight gain 
below IOM in overweight 
pre-gestational weight (OR: 
0.76); overweight pre-
gestational weight gain in 
overweight pre-gestational 
weight (OR: 1.24) 
 
Islam MM, et 
al. 2015.8 
Retrospective 
cohort 
Oman 1,711 N/A 32 Chi-square test, T-
test 
Maternal age ≥ 35 (OR: 3) 16.6 
Kumru P, et al. 
2014.9 
Cohort  Mardin, 
Turkey 
395 10-12 w N/A Logistic regression, 
Chi-square, student 
T-test, Fischer’s 
exact test 
Isolated anti TPO antibody 
(OR: 0.7); sub-clinic 
hiypothyroidism (OR: 1.1); 
sub-clinic hypothyroidism 
with anti TPO (OR : 1.55) 
19.6 
Lee CJ, et al. 
1999.10 
Retrospective 
cohort 
Taipei, 
Taiwan 
29 375  20 w 20-34 Multivariate logistic 
regression, chi 
square, T-test, 
Fischer’s exact 
History of preeclampsia 
(OR: 6.3); multiple 
gestation (OR: 3.6); 
pregnancy body mass 
>24.2 (OR: 2.4); age >34 
years (OR: 1.8); nulliparity 
(OR: 1.3); urinary tract 
17 
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Author and 
Year of 
Publication  
Study Design Location 
of Study 
Sample 
Size 
Gestational 
Age 
Mean Age 
of Sample 
Method of Analysis Outcome Strobe 
infection during pregnancy 
(OR: 4.8); worked during 
pregnancy (OR: 1.9); 
normal BMI(OR: 0.6) 
 
Leung TY, et 
al. 2008.11 
Retrospective 
cohort 
Hong 
Kong 
29.303 20 w 31 Univariate and 
multivariate logistic 
regression 
 
BMI<18.5 (OR: 0.9) ; 
obesity(OR: 3.97) 
19.2 
LI X, et al. 
2015.12 
Retrospective 
cohort 
Liuyang, 
China 
6,223 N/A N/A Chi-square test, 
Fisher's exact test, 
univariate  and 
multivariate logistic 
regression, two-
tailed hypothesis 
test 
Maternal age >35 (OR 
3.34); BMI 24-28 (OR 
1.98); BMI ≥ 28 (OR= 
3.41);  GDM (OR: 18.01); 
Diabetes Mellitus/renal 
disease/cardiac disease 
(OR: 4.24); fetal sex male 
(OR: 0.65) 
 
20.4 
Li Z, et al. 
2013.13 
Cohort  Beijing, 
China 
193.554 N/A N/A Logistic regression Age continuous (RR: 1.06); 
BMI continuous (RR; 
1.07); factory worker 
(RR:1.04); other 
occupation (RR:1.12); 
junior high school 
(RR:1.18); prim 
 
16.1 
Marsoosi V, et 
al. 2011.14 
cohort Tehran, 
Iran 
2219 17-24 w 27.2 Univariate and 
multivariablelogistic 
regression 
BPD <10 (OR:1.04); BPD 
>90 (OR: 0.86) 
15.2 
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Author and 
Year of 
Publication  
Study Design Location 
of Study 
Sample 
Size 
Gestational 
Age 
Mean Age 
of Sample 
Method of Analysis Outcome Strobe 
Park JH, et al. 
2011.15 
Retrospective 
cohort 
Seoul, 
Korea 
2311 28-42 w N/A Univariate and 
multivariate logistic 
regression, Chi 
square test 
BMI underweight (OR: 
1.1); overweight (OR: 2.4); 
maternal weight gain 
<10kg (OR: 0.5); maternal 
weight gain ≥16 kg 
(OR:0.6) 
 
15.9 
Shetty M, et al. 
2010.16 
Cohort India 130 28.9 ± 1.7 
w 
26.8 ± 3.7 Multiple logistic 
regression, (Chi-
square test) 
 
Working (OR: 2.63); 
nuliparity (OR: 4.04) 
14.2 
Taguchi T, et 
al. 2014.17 
Retrospective 
cohort 
Osaka, 
Japan 
742 <14 w N/A Multivariable 
logistic regression 
IN TWIN PREGNANCIES 
- primipara (OR: 1.77); pre-
gastational BMI (OR: 
1.35); family history 
hypertension (OR: 1.5) 
IN MULTIPARA 
PREGNANCIES - previous 
history of gestational 
hypertension or 
preeclampsia (OR: 8.85) 
 
16.5 
Wei YM, et al. 
2015.18 
Cohort Beijing, 
China 
14.451 N/A N/A Multivariate 
analysis 
BMI overweight (OR: 
2.26); obese (OR: 4.49); 
GDM with overweight 
(OR: 1.9); GDM with 
obese (OR: 1.89; non GDM 
with overweight (OR: 
13.1 
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Author and 
Year of 
Publication  
Study Design Location 
of Study 
Sample 
Size 
Gestational 
Age 
Mean Age 
of Sample 
Method of Analysis Outcome Strobe 
2.29); nonGDM withobese 
(OR: 6.1) 
Yu S, et al. 
2007.19 
Retrospective 
cohort 
Beijing, 
china 
1.499 N/A 30.5-30.7 Chi square, fFscher 
exact test 
Chronic hypertension(OR: 
7.174) ; increasing pre-
pregnancy BMI (OR: 
1.131) 
15 
 
 
